ETF Managers Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-117,646
| Closed | -$104K | – | 757 |
|
|
2022
Q4 | $104K | Sell |
117,646
-15,132
| -11% | -$13.4K | ﹤0.01% | 490 |
|
|
2022
Q3 | $208K | Buy |
132,778
+9,896
| +8% | +$15.5K | 0.01% | 594 |
|
|
2022
Q2 | $245K | Buy |
122,882
+27,465
| +29% | +$54.8K | 0.01% | 625 |
|
|
2022
Q1 | $226K | Buy |
95,417
+2,391
| +3% | +$5.66K | ﹤0.01% | 596 |
|
|
2021
Q4 | $456K | Buy |
+93,026
| New | +$456K | 0.01% | 530 |
|
|
2021
Q2 | – | Sell |
-1,092
| Closed | -$9K | – | 815 |
|
|
2021
Q1 | $9K | Sell |
1,092
-115,329
| -99% | -$951K | ﹤0.01% | 660 |
|
|
2020
Q4 | $842K | Buy |
116,421
+24,884
| +27% | +$180K | 0.02% | 255 |
|
|
2020
Q3 | $1.06M | Buy |
91,537
+23,999
| +36% | +$278K | 0.03% | 200 |
|
|
2020
Q2 | $413K | Buy |
+67,538
| New | +$413K | 0.01% | 291 |
|